A randomized trial comparing zoladex 3.6 mg depot with stilboestrol 3mg/day in advanced prostate cancer: Patient characteristics, response and treatment failures

✍ Scribed by Trethowan, C.; Hilton, C.; Arkell, D.G.; Wallace, D..A.; Hughes, M.A.; Farrar, D.J.; Young, C.; Jones, M.; Hay, A.M.; Emtage, L.A.

• Book ID: 123048446
• Publisher: Elsevier Science
• Year: 1987
• Weight: 141 KB
• Volume: 23
• Category: Article
• ISSN: 0277-5379
• DOI: 10.1016/0277-5379(87)90194-5